Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind study of Maxidex versus Lacrystat to prevent docetaxel-induced dacryostenosis
2005-005174-68Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dacryostenosis comparing Maxidex + docetaxel with Lacrystat + docetaxel (2 arms). Started Dec 2005; status: completed.
02
Drugs
dexamethasoneLacrystat
03
Conditions
dacryostenosis
Beyond the preview
Go deeper on 2005-005174-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005174-68.